Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27
+0.82002.03%
Post-market: 41.270.00000.00%18:39 EDT
Volume:1.26M
Turnover:52.12M
Market Cap:1.06B
PE:- -
High:41.37
Open:40.60
Low:40.60
Close:40.45
52wk High:43.52
52wk Low:28.77
Shares:25.80M
Float Shares:25.80M
Volume Ratio:15.04
T/O Rate:4.90%
Dividend:0.29
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

OverviewCompanyNewsFilings

Merck announces one-year results from Phase 2b/3 Brunello trial

TIPRANKS
·
1 hour ago

Wells Fargo, Bank of America, Domino's, Johnson & Johnson, Inflation Data, and More to Watch This Week

Dow Jones
·
2 hours ago

AbbVie Says Phase 3 Affirm Study Shows Subcutaneous Skyrizi Beats Placebo on Crohn’s Remission, Endoscopic Response at Week 12

Reuters
·
3 hours ago

Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial

Simply Wall St.
·
Yesterday

Merck Says Remigromig Meets Primary Endpoint in Brunello Diabetic Macular Edema Trial at One Year

Reuters
·
Yesterday

Merck Presents One-Year Results from the Pivotal Phase 2B/3 Brunello Study Evaluating Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at Aao 2026

THOMSON REUTERS
·
Yesterday

Merck & Co - Remigromig Demonstrates Non-Inferior Visual Acuity Versus Ranibizumab at One Year in Dme

THOMSON REUTERS
·
Yesterday

Johnson & Johnson (JNJ) Faces Fresh Patent Lawsuit Over Cardiology Device

Simply Wall St.
·
Oct 10

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 10

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
Oct 10

Pacira Biosciences' Acquisition by Viatris Unlikely to See Superior Bid, RBC Says

MT Newswires Live
·
Oct 09

UBS Lifts AbbVie Target as Focus Expands Beyond Immunology Drugs

Reuters
·
Oct 09

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Oct 09

Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look

TIPRANKS
·
Oct 09

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Oct 09

Abbvie Inc. : UBS Raises Target Price to $275 from $260

THOMSON REUTERS
·
Oct 09

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Oct 09

Merck & Company (MRK) Receives a Buy from UBS

TIPRANKS
·
Oct 09
More